The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Can advanced-stage ovarian cancer be cured?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
McGuire, W. P., Hoskins, W. J., Brady, M. F., Kucera, P. R., Partridge, E. E., Look, K. Y., Clarke-Pearson, D. L., & Davidson, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340101 · Cited by 2,796
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Vergote, I., Tropé, C. G., Amant, F., Kristensen, G. B., Ehlen, T., Johnson, N., Verheijen, R. H. M., van der Burg, M. E. L., Lacave, A. J., Panici, P. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908806 · Cited by 2,537
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Burger, R. A., Brady, M. F., Bookman, M. A., Fleming, G. F., Monk, B. J., Huang, H., Mannel, R. S., Homesley, H. D., Fowler, J., Greer, B. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104390 · Cited by 2,404
A Phase 3 Trial of Bevacizumab in Ovarian Cancer
Perren, T. J., Swart, A. M., Pfisterer, J., Ledermann, J. A., Pujade-Lauraine, E., Kristensen, G., Carey, M. S., Beale, P., Cervantes, A., Kurzeder, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103799 · Cited by 2,172
Ozols, R. F., Bundy, B. N., Greer, B. E., Fowler, J. M., Clarke-Pearson, D., Burger, R. A., Mannel, R. S., DeGeest, K., Hartenbach, E. M., & Baergen, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.153 · Cited by 2,032
du Bois, A., Reuss, A., Pujade‐Lauraine, E., Harter, P., Ray‐Coquard, I., & Pfisterer, J. (2009) · Cancer · doi:10.1002/cncr.24149 · Cited by 1,638
GLOBOCAN 2008 v1.2, Cancer incidence and mortality world-wide : IARC Cancer Base No. 10
Ferlay, J. (2010) · Medical Entomology and Zoology · Cited by 1,633
Pujade-Lauraine, E., Hilpert, F., Weber, B., Reuss, A., Poveda, A., Kristensen, G., Sorio, R., Vergote, I., Witteveen, P., Bamias, A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.4489 · Cited by 1,622
Whole–genome characterization of chemoresistant ovarian cancer
Patch, A.-M., Christie, E. L., Etemadmoghadam, D., Garsed, D. W., George, J., Fereday, S., Nones, K., Cowin, P., Alsop, K., Bailey, P. J., et al. (2015) · Nature · doi:10.1038/nature14410 · Cited by 1,569
Kehoe, S., Hook, J., Nankivell, M., Jayson, G. C., Kitchener, H., Lopes, T., Luesley, D., Perren, T., Bannoo, S., Mascarenhas, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62223-6 · Cited by 1,414
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
Bowtell, D. D., Böhm, S., Ahmed, A. A., Aspuria, P.-J., Bast, R. C., Beral, V., Berek, J. S., Birrer, M. J., Blagden, S., Bookman, M. A., et al. (2015) · Nature Reviews Cancer · doi:10.1038/nrc4019 · Cited by 1,367
Self-citationAlberts, D. S., Liu, P. Y., Hannigan, E. V., O'Toole, R., Williams, S. D., Young, J. A., Franklin, E. W., Clarke-Pearson, D. L., Malviya, V. K., DuBeshter, B., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352603 · Cited by 1,228
HALSTED, W. S. (1894) · Annals of Surgery · doi:10.1097/00000658-189407000-00075 · Cited by 935
Metastatic patterns in adenocarcinoma
Hess, K. R., Varadhachary, G. R., Taylor, S. H., Wei, W., Raber, M. N., Lenzi, R., & Abbruzzese, J. L. (2006) · Cancer · doi:10.1002/cncr.21778 · Cited by 820
Oza, A. M., Cibula, D., Benzaquen, A. O., Poole, C., Mathijssen, R. H. J., Sonke, G. S., Colombo, N., Špaček, J., Vuylsteke, P., Hirte, H., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71135-0 · Cited by 547
Katsumata, N., Yasuda, M., Isonishi, S., Takahashi, F., Michimae, H., Kimura, E., Aoki, D., Jobo, T., Kodama, S., Terauchi, F., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70363-2 · Cited by 480
Chang, S.-J., Hodeib, M., Chang, J., & Bristow, R. E. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.05.040 · Cited by 433
Tewari, D., Java, J. J., Salani, R., Armstrong, D. K., Markman, M., Herzog, T., Monk, B. J., & Chan, J. K. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.9898 · Cited by 288
Horowitz, N. S., Miller, A., Rungruang, B., Richard, S. D., Rodriguez, N., Bookman, M. A., Hamilton, C. A., Krivak, T. C., & Maxwell, G. L. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.3106 · Cited by 252
Suidan, R. S., Ramirez, P. T., Sarasohn, D. M., Teitcher, J. B., Mironov, S., Iyer, R. B., Zhou, Q., Iasonos, A., Paul, H., Hosaka, M., et al. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.07.002 · Cited by 225
Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer
Cress, R. D., Chen, Y. S., Morris, C. R., Petersen, M., & Leiserowitz, G. S. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000981 · Cited by 201
Ovarian Cancer, Version 3.2012
Morgan, R. J., Alvarez, R. D., Armstrong, D. K., Burger, R. A., Castells, M., Chen, L.-M., Copeland, L., Crispens, M. A., Gershenson, D., Gray, H., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0140 · Cited by 195
Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer
Wright, A. A., Cronin, A., Milne, D. E., Bookman, M. A., Burger, R. A., Cohn, D. E., Cristea, M. C., Griggs, J. J., Keating, N. L., Levenback, C. F., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.4776 · Cited by 185
Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2
McLaughlin, J. R., Rosen, B., Moody, J., Pal, T., Fan, I., Shaw, P. A., Risch, H. A., Sellers, T. A., Sun, P., & Narod, S. A. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs494 · Cited by 168
Self-citationTutt, A., Ellis, P., Kilburn, L., Gilett, C., Pinder, S., Abraham, J., Barrett, S., Barrett-Lee, P., Chan, S., Cheang, M., et al. (2015) · Cancer Research · doi:10.1158/1538-7445.sabcs14-s3-01 · Cited by 167
Candido-dos-Reis, F. J., Song, H., Goode, E. L., Cunningham, J. M., Fridley, B. L., Larson, M. C., Alsop, K., Dicks, E., Harrington, P., Ramus, S. J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2497 · Cited by 161
Lesnock, J. L., Darcy, K. M., Tian, C., DeLoia, J. A., Thrall, M. M., Zahn, C. M., Armstrong, D. K., Birrer, M. J., & Krivak, T. C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.70 · Cited by 152
Landrum, L. M., Java, J., Mathews, C. A., Lanneau, G. S., Copeland, L. J., Armstrong, D. K., & Walker, J. L. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.04.001 · Cited by 149
Engel, J., Eckel, R., Schubert-Fritschle, G., Kerr, J., Kuhn, W. C., Diebold, J., Kimmig, R., Rehbock, J., & Hölzel, D. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00495-1 · Cited by 142
Ovarian Cancer, Version 2.2013
Morgan, R. J., Alvarez, R. D., Armstrong, D. K., Burger, R. A., Chen, L.-M., Copeland, L. J., Crispens, M. A., Gershenson, D. M., Gray, H. J., Hakam, A., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0142 · Cited by 142
A framework for a personalized surgical approach to ovarian cancer
Nick, A. M., Coleman, R. L., Ramirez, P. T., & Sood, A. K. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.26 · Cited by 131
Why have ovarian cancer mortality rates declined? Part I. Incidence
Sopik, V., Iqbal, J., Rosen, B. P., & Narod, S. A. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.06.017 · Cited by 128
Self-citationRosen, B. P., Laframboise, S., Ferguson, S. E., Dodge, J. E., Bernardini, M. Q., Murphy, J., Segev, Y., Sun, P., & Narod, S. A. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.07.004 · Cited by 119
Self-citationTen-year survival after epithelial ovarian cancer is not associated with BRCA mutation status
Kotsopoulos, J., Rosen, B. P., Fan, I., Moody, J., McLaughlin, J. R., Risch, H. A., May, T., Sun, P., & Narod, S. A. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.11.009 · Cited by 116
Self-citationAlternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer
Gray, H. J., Shah, C., Swensen, R. E., Tamimi, H. K., & Goff, B. A. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.10.054 · Cited by 19
Cited by
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Lisio, M.-A., Fu, L., Goyeneche, A., Gao, Z.-H., & Telleria, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040952 · Cited by 680
CA125 and Ovarian Cancer: A Comprehensive Review
Charkhchi, P., Cybulski, C., Gronwald, J., Wong, F. O., Narod, S. A., & Akbari, M. R. (2020) · Cancers · doi:10.3390/cancers12123730 · Cited by 602
Self-citationFluorescent Probes for Disease Diagnosis
Wang, X., Ding, Q., Groleau, R. R., Wu, L., Mao, Y., Che, F., Kotova, O., Scanlan, E. M., Lewis, S. E., Li, P., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00776 · Cited by 543
Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids
Hill, S. J., Decker, B., Roberts, E. A., Horowitz, N. S., Muto, M. G., Worley, M. J., Feltmate, C. M., Nucci, M. R., Swisher, E. M., Nguyen, H., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0474 · Cited by 452
Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
Larionova, I., Tuguzbaeva, G., Ponomaryova, A., Stakheyeva, M., Cherdyntseva, N., Pavlov, V., Choinzonov, E., & Kzhyshkowska, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.566511 · Cited by 392
Metadata
- Authors
- Narod, S.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2016-01-20
- Volume
- 13
- Issue
- 4
- Pages
- 255-261
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2269087069
- Cited by
- 369
- References
- 37
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.